medalphabetМедицинский алфавитMedical alphabet2078-56312949-2807ООО «Альфмед»10.33667/2078-5631-2020-5-8-12medalphabet-1458Research ArticleСтатьиАнализ лабораторного мониторинга и перспективы использования его результатов в деятельности специализированной клинико-диагностической лабораторииLaboratory monitoring analysis and prospects for using its results in specialized clinical diagnostic laboratoryБибиковаВ. В.BibikovaV. V.

ассистент Научно-методического центра по молекулярной медицине Минздрава России

г. Санкт-Петербург

Saint Petersburg

ЭмануэльВ. Л.EmanuelV. L.

д. м. н., проф., зав. кафедрой клинической лабораторной диагностики с курсом молекулярной медицины, директор Научно-методического центра по молекулярной медицине Минздрава России

г. Санкт-Петербург

Saint Petersburg

ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет имени академика И. П. Павлова» Минздрава РоссииРоссияFirst Saint Petersburg State Medical University n. a. I. P. PavlovRussian Federation20201506202005Современная лаборатория812Copyright © Бибикова В.В., Эмануэль В.Л., 20202020Бибикова В.В., Эмануэль В.Л.Bibikova V.V., Emanuel V.L.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-alphabet.com/jour/article/view/1458

В статье представлен ретроспективный анализ заявок, поступивших в специализированную клинико-диагностическую лабораторию (КДЛ) для проведения лабораторного мониторинга. Установлено, что в процессе деятельности специализированной КДЛ накапливаются большие массивы информации о редких, недостаточно изученных заболеваниях и особых видах патологии. Выявлено, что доля мониторинговых направлений на обследование составляет 17 % и имеет тенденцию к росту, что может быть связано с совершенствованием методов лабораторной диагностики. Обсуждается возможность использования результатов лабораторного мониторинга для улучшения диагностического процесса путем составления оптимального алгоритма обследования пациентов, а также для изучения регионарной патологии. Оценены перспективы использования информации о лабораторном мониторинге в совершенствовании организации деятельности специализированной КДЛ.

This article presents a retrospective analysis of the laboratory monitoring orders from the specialized clinical laboratory. It has been established that large amounts of information about rare, poorly understood diseases and special types of pathology are accumulated during the everyday activity of specialized clinical laboratory. This research indicated that the share of laboratory monitoring, with 17 % of all orders, has a tendency to increase, which may be associated with the improvement of laboratory diagnostic methods. The possibility of laboratory monitoring results using in order to facilitate diagnostic process by the means of an optimal examination algorithm compiling, as well as to study regional pathology, is discussed. Besides, the prospects of using information on laboratory monitoring in improving the organization of specialized clinical laboratory’s activity are assessed.

специализированная клинико-диагностическая лабораториялабораторный мониторингнаправление на обследованиесовершенствование диагностического процессаорганизация деятельности КДЛspecialized clinical laboratorylaboratory monitoringlaboratory orderdiagnostic process improvementorganization of clinical laboratory’s activityReferencesGeerts A., De Koning F., Van Solinge W., De Smet P. and Egberts T. (2012). Instructions on laboratory monitoring in 200 drug labels. Clinical Chemistry and Laboratory Medicine, 50 (8).Geerts A., De Koning F., Van Solinge W., De Smet P. and Egberts T. (2012). Instructions on laboratory monitoring in 200 drug labels. Clinical Chemistry and Laboratory Medicine, 50 (8).Giacomelli R, Afeltra A, Alunno A, Baldini C, Bartoloni-Bocci E, Berardicurti O, Carubbi F, Cauli A, Cervera R, Ciccia F, Cipriani P, Conti F, De Vita S, Di Benedetto P, Doria A, Drosos AA, Favalli EG, Gandolfo S, Gatto M, Grembiale RD, Liakouli V, Lories R, Lubrano E, Lunardi C, Margiotta DPE, Massaro L, Meroni P, Minniti A, Navarini L, Pendolino M, Perosa F, Pers JO, Prete M, Priori R, Puppo F, Quartuccio L, Ruffatti A, Ruscitti P, Russo B, Sarzi-Puttini P, Shoenfeld Y, Somarakis GA, Spinelli FR, Tinazzi E, Triolo G, Ursini F, Valentini G, Valesini G, Vettori S, Vitali C, Tzioufas AG. International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren’s syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. Autoimmun Rev. 2017 Sep; 16 (9): 911–924.Giacomelli R, Afeltra A, Alunno A, Baldini C, Bartoloni-Bocci E, Berardicurti O, Carubbi F, Cauli A, Cervera R, Ciccia F, Cipriani P, Conti F, De Vita S, Di Benedetto P, Doria A, Drosos AA, Favalli EG, Gandolfo S, Gatto M, Grembiale RD, Liakouli V, Lories R, Lubrano E, Lunardi C, Margiotta DPE, Massaro L, Meroni P, Minniti A, Navarini L, Pendolino M, Perosa F, Pers JO, Prete M, Priori R, Puppo F, Quartuccio L, Ruffatti A, Ruscitti P, Russo B, Sarzi-Puttini P, Shoenfeld Y, Somarakis GA, Spinelli FR, Tinazzi E, Triolo G, Ursini F, Valentini G, Valesini G, Vettori S, Vitali C, Tzioufas AG. International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren’s syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. Autoimmun Rev. 2017 Sep; 16 (9): 911–924.Raebel M, Lyons E, Andrade S et al. Laboratory monitoring of drugs at initiation of therapy in ambulatory care. J Gen Intern Med. 2005; 20 (12): 1120–1126. DOI: 10.1111/j.1525–1497.2005.0257.x.Raebel M, Lyons E, Andrade S et al. Laboratory monitoring of drugs at initiation of therapy in ambulatory care. J Gen Intern Med. 2005; 20 (12): 1120–1126. DOI: 10.1111/j.1525–1497.2005.0257.x.Rigby W., Lampl K., Low J. and Furst D. (2017). Review of Routine Laboratory Monitoring for Patients with Rheumatoid Arthritis Receiving Biologic or Nonbiologic DMARDs. International Journal of Rheumatology, 2017, pp. 1–15.Rigby W., Lampl K., Low J. and Furst D. (2017). Review of Routine Laboratory Monitoring for Patients with Rheumatoid Arthritis Receiving Biologic or Nonbiologic DMARDs. International Journal of Rheumatology, 2017, pp. 1–15.Stephenson D., Hu M., Romero K., Breen K., Burn D., Ben-Shlomo Y., Bhattaram A., Isaac M., Venuto C., Kubota K., Little M., Friend S., Lovestone S., Morris H., Grosset D., Sutherland M., Gallacher J., Williams-Gray C., Bain L., Avilés E., Marek K., Toga A., Stark Y., Forrest Gordon M. and Ford S. (2015). Precompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson’s Disease 1. Journal of Parkinson’s Disease, 5 (3), pp. 581–594.Stephenson D., Hu M., Romero K., Breen K., Burn D., Ben-Shlomo Y., Bhattaram A., Isaac M., Venuto C., Kubota K., Little M., Friend S., Lovestone S., Morris H., Grosset D., Sutherland M., Gallacher J., Williams-Gray C., Bain L., Avilés E., Marek K., Toga A., Stark Y., Forrest Gordon M. and Ford S. (2015). Precompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson’s Disease 1. Journal of Parkinson’s Disease, 5 (3), pp. 581–594.The Autoimmune Registry. (2019). List of Autoimmune Diseases – The Autoimmune Registry. [online] Available at: www.autoimmuneregistry. org/the-list-1 [Accessed 12 Oct. 2019].The Autoimmune Registry. (2019). List of Autoimmune Diseases – The Autoimmune Registry. [online] Available at: www.autoimmuneregistry. org/the-list-1 [Accessed 12 Oct. 2019].Wiik A., Gordon T., Kavanaugh A., Lahita R., Reeves W., van Venrooij W., Wilson M. and Fritzler M. (2004). Cutting edge diagnostics in rheumatology: The role of patients, clinicians, and laboratory scientists in optimizing the use of autoimmune serology. Arthritis Care & Research, 51 (2), pp. 291–298.Wiik A., Gordon T., Kavanaugh A., Lahita R., Reeves W., van Venrooij W., Wilson M. and Fritzler M. (2004). Cutting edge diagnostics in rheumatology: The role of patients, clinicians, and laboratory scientists in optimizing the use of autoimmune serology. Arthritis Care & Research, 51 (2), pp. 291–298.Winthrop K., Strand V., van der Heijde D., Mease P., Crow M., Weinblatt M., Bathon J., Burmester G., Dougados M., Kay J., Mariette X., van Vollenhoven R., Sieper J., Melchers F., Breedfeld F., Kalden J., Smolen J. and Furst D. (2018). The unmet need in rheumatology: Reports from the targeted therapies meeting 2017. Clinical Immunology, 186, pp. 87–93.Winthrop K., Strand V., van der Heijde D., Mease P., Crow M., Weinblatt M., Bathon J., Burmester G., Dougados M., Kay J., Mariette X., van Vollenhoven R., Sieper J., Melchers F., Breedfeld F., Kalden J., Smolen J. and Furst D. (2018). The unmet need in rheumatology: Reports from the targeted therapies meeting 2017. Clinical Immunology, 186, pp. 87–93.Winthrop K., Weinblatt M., Crow M., Burmester G., Mease P., So A., Bykerk V., van Vollenhoven R., Dougados M., Kay J., Mariette X., Sieper J., Melchers F., Cronstein B., Shevach E., Breedfeld F., Kalden J., Smolen J. and Furst D. (2019). Unmet need in rheumatology: reports from the Targeted Therapies meeting 2018. Annals of the Rheumatic Diseases, 78 (7), pp. 872–878.Winthrop K., Weinblatt M., Crow M., Burmester G., Mease P., So A., Bykerk V., van Vollenhoven R., Dougados M., Kay J., Mariette X., Sieper J., Melchers F., Cronstein B., Shevach E., Breedfeld F., Kalden J., Smolen J. and Furst D. (2019). Unmet need in rheumatology: reports from the Targeted Therapies meeting 2018. Annals of the Rheumatic Diseases, 78 (7), pp. 872–878.

The authors declare that there are no conflicts of interest present.